Department of the Army April 2008 – Federal Register Recent Federal Regulation Documents
Results 1 - 10 of 10
Notice of Availability of a Novel UV Emitting Device for Exclusive, Partially Exclusive or Non-Exclusive Licenses
The Department of the Army announces the general availability of exclusive, partially exclusive or non-exclusive licenses relative to a novel ultraviolet light emitting device as described in U.S. Patent Applications 11/376,453, Ultraviolet Light Emitting AlGaN Composition and Ultraviolet Light Emitting Device Containing Same and 11/376,452 Method of Manufacturing an Ultraviolet Light Emitting AlGaN Composition and Ultraviolet Light Emitting Device Containing Same. Any license shall comply with 35 U.S.C. 209 and 37 CFR 404.
Army Science Board Plenary Meeting
Pursuant to the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Sunshine in the Government Act of 1976 (U.S.C. 552b, as amended) and 41 Code of the Federal Regulations (CFR 102-3. 140 through 160, the Department of the Army announces the following committee meeting: Name of Committee: Army Science Board (ASB). Date(s) of Meeting: May 20-21, 2008. Time(s) of Meeting: 0800-1700, May 20, 2008-1300-1600, May 21, 2008. Place of Meeting: Minute Maid Park, 6580 Fannin Street, Houston, TX.
Employment of Troops in Aid of Civil Authorities
This action removes 32 CFR Part 501, Employment of Troops in Aid of Civil Authorities. The regulations are being removed because they are obsolete and no longer govern policies for the Department of the Army in planning and operations involving the use of Army resources in the control of actual or anticipated civil disturbances. The program responsibility has been transferred to the Office of the Assistant Secretary of Defense for Homeland Defense.
Relief Assistance
This action removes 32 CFR Part 502, Relief Assistance. The regulations are being removed because they are obsolete and no longer govern policies and procedures for disaster relief activities. The program responsibility has been transferred to the Office of the Assistant Secretary of Defense for Homeland Defense.
Availability of Non-Exclusive, Exclusive License or Partially Exclusive Licensing of U.S. Patent Concerning Assembled Hematin, Method for Forming Same and Method for Polymerizing Aromatic Monomers Using Same
In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent No. U.S. 7,344,751 entitled ``Assembled Hematin, Method for Forming Same and Method for Polymerizing Aromatic Monomers Using Same'' issued March 18, 2008. This patent has been assigned to the United States Government as represented by the Secretary of the Army.
Availability of Non-Exclusive, Exclusive License or Partially Exclusive Licensing of U.S. Patent Concerning Apparatus and Method To Test Abrasion Resistance of Material Using Airborne Particulate
In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent No. U.S. 7,347,768 entitled ``Apparatus and Method to Test Abrasion Resistance of Material Using Airborne Particulate'' issued March 25, 2008. This patent has been assigned to the United States Government as represented by the Secretary of the Army.
Availability of the Record of Decision (ROD) for the Permanent Stationing of the 2/25th Stryker Brigade Combat Team (SBCT)
The Deputy Chief of Staff of the Army, G-3/5/7 has reviewed the Final Environmental Impact Statement (FEIS) for the Permanent Stationing of the 2/25th SBCT and has made the decision to proceed with all facets of Alternative A. Alternative A permanently stations the 2/ 25th SBCT at Schofield Barracks Military Reservation (SBMR) while conducting the required training at military training sites in Hawaii. This alternative is summarized in the Army's ROD and described fully in Chapter 2 of the FEIS.
Intent To Grant an Exclusive License of a U.S. Government-Owned Patent
In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(I)(i), announcement is made of the intent to grant an exclusive, royalty- bearing, revocable license to U.S. Patent 6,825,323, filed January 10, 2001, entitled ``Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using the same'' and foreign rights (PCT/US01/000725) to ProFibrix B.V., with its principal place of business at Zernikedreef 9, 2333 CK Leiden, The Netherlands.
Advisory Committee Meeting Notice
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), announcement is made of the following meeting:
Army Educational Advisory Committee
Pursuant to the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Sunshine in the Government Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, the following meeting notice is announced:
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
